Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Closed Date7/2013

General Information

Websitespringleaftx.com
CategoryBioTech
Phone1-617-358-4927
Emailinfo@springleaftx...
Employees

Offices

Boston, USA
8 St. Mary's Street
Suite 601
Boston, MA, 02215
USA

People

CEO
President and CEO
Board of Directors

Funding

TOTAL $23.3M
FUNDING TOTAL $23.3M
Series A, 11/2009
Flybridge Capital Partners
North Bridge Venture Partners
$4.23M
Series B, 7/2011
Excel Venture Management
GSK Venture Fund
$19M

Tags

Springleaf Therapeutics Closed down July, 2013

Springleaf Therapeutics

SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on convergent science and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including Flybridge Capital Partners and North Bridge Venture Partners.

Recent Milestones

Videos

Screenshots

Springleaf Therapeutics screenshot
Above: Springleaf Therapeutics
Uploaded: 5/12/11

Sources

  1. Entra Pharmaceuticals gathers first round funds (bizjournals.com) [edit]
  2. SEC (sec.gov) [edit]
Edit This Page
Last Edited 2/18/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy